Pharma and medtech representatives gave their feedback on the European Medicines Agency’s proposed regulatory strategy for AI during a hybrid workshop this week, which saw hundreds of industry stakeholders assemble in-person and online.
Stephen Pyke, chief clinical data and digital officer for real-world evidence and AI innovation at the CRO Parexel, said during the meeting that agencies should be “aware of inconsistencies in the approach or undesirable restrictions,